Healthcare
Live Price
Offline$1.40
-22.22% today
1Y Change
+324.35%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Veri Medtech Holdings Inc. (VRHI) is a Healthcare stock with a market cap of $20.00M and listed on OTC. The stock last traded around $1.40 and up 324.3% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +210.4%, EPS growth of -57.1%, a dividend yield of 0.0%. What stands out right now is revenue +210.4%, EPS -57.1%, free cash flow -180.4% with operating margin -79.3% and ROIC -37.2%. Valuation already assumes a fairly strong business story at price/sales 256.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VRHI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRHI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VRHI Max Drawdown
-51.50%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VRHI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$10.1K
-93.2% YoY
FY Net Income
-$64.1K
+46.2% YoY
Free Cash Flow
-$74.4K
+17.2% YoY
Revenue Growth
+210.4%
EPS Growth
-57.1%
Gross Margin
85.5%
Net Margin
-79.3%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 78K | 25K | 49K | 149K | 10K |
| Gross Profit | 67K | 21K | 38K | 125K | 8K |
| Operating Income | -62K | -39K | -224K | -114K | -53K |
| EBITDA | -60K | -39K | -31K | -113K | -53K |
| Net Income | -62K | -39K | -33K | -119K | -64K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 27K | 31K | 185K | 143K | 7K |
| Total Assets | 166K | 286K | 350K | 310K | 170K |
| Total Liabilities | 4K | 62K | 272K | 2K | 67K |
| Shareholder Equity | 162K | 224K | 78K | 309K | 103K |
| Total Debt | 0 | 0 | 0 | 0 | 65K |
| Net Debt | -27K | -31K | -185K | -143K | 58K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
74K
+12.8% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
74K
+17.2% YoY
Key ratios
Gross Margin
85.5%
Operating Margin
-79.3%
Net Margin
-79.3%
ROE
-32.1%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.